Moderna and Carisma collaborate to develop in-vivo engineered CAR-M for oncology EP News Bureau Jan 11, 2022 The companies have partnered to discover, develop and commercialise in-vivo engineered Chimeric Antigen Receptor Monocyte (CAR-M)…
